Falk Symposium

Gut and the Liver: Proceedings of the Falk Symposium 100 (Part III of the Intestinal Week in the Black Forest 1997) Held in Freiburg, Germany, May 29-30, 1997 - Falk Symposium

Marc Notes: Includes bibliographical references and index. Table of Contents: Preface. Section I: The Milieu Exterieur' and Milieu Interieur' in the Gut: Confrontation and Cooperation. 1. Intestinal Microbiota: Control and Overgrowth; A. B. Onderdonk. 2. The Intestinal Immune System; T. Marth, M. Zeitz. Section II: Gastrointestinal Permeability and Translocation. 3. The Intestinal Permeability Barrier - What is Measured, What Does It Mean; S. Gabe, et al. 4. Bacterial Translocation; R. D. Berg. 5. Intestinal Permeability in Inflammatory Bowel Disease; 6. Intestinal Absorption of Small Particles; J. Seifert. Section III: Bile Acid, Amino Acid and Drug Metabolism - It's Not Only the Liver, it May be the Gut. 7. State of the Art Lecture: Bacterial Enzymes and Bile Acid Metabolism: Peaceful Coexistence vs. Deadly Warfare; A. F. Hofmann. 8. Gastric First Pass Metabolism of Alcohol: Interaction with Ammonia and Associated Gastritis; C. S. Lieber. 9. Ethanol Oxidation and Acetaldehyde Production by Colonic Microbes; M. Salaspuro, et al. 10. Adaptation of Liver Cell Function to Enteral Resorption: Role of Cell Liver Hydration; D. Hassinger, et al. 11. Amino Acid Metabolism in the Gut; M. Plauth, A. E. Roske. 12. Drug Metabolism in the Intestinal Wall; U. Klotz. The Role of Gut Bacteria in Drug Metabolism; T. M. Bauer. Section IV: Gut-Derived Bacterial Toxins and Liver Injury. 14. How Bacterial Toxins Affect the Intestinal Mucosa - Molecular Mechanism of the Action of Clostridium Difficile Toxins; K. Aktories. 15. Acute and Chronic Endotoxemia: Effects on Hepatic Neutrophil Influx and Respiratory Burst; J. A. Spitzer. 16. Experimental Liver Injury: The Role of Lipopolysaccharides and Cytokines; A. Wendel, et al. 17. Endotoxin, Kupffer Cells and Alcoholic Liver Injury; R. G. Thurman, et al. 18. Hepatic Injury and Biliary Tract Diseases Associated with Small Intestinal Bacterial Overgrowth; R. B. Sartor, S. N. Lichtman. 19. Endotoxemia in Chronic Hepatitis and Cirrhosis: Epiphenomenon or of Pathological Relevance? H. Fukui, et al. 20. Endotoxemia and Disseminated Intravascular Coagulation in Cirrhosis; F. Violi, et al. 21. The Role of Gut-Derived Bacterial Toxins (Endotoxin) for the Development of Alcoholic Liver Disease in Man; Ch. Bode, et al. 22. Endotoxaemia and Cholestasis; E. Walter. 23. Adverse Effects of Gut-Derived Bacterial Toxins in Liver Transplantation; W. Lauchart. Section V: Gastrointestinal Dysfunction in Liver Disease. 24. Altered Gastrointestinal Motility in Chronic Liver Disease; R. K. Zetterman. 25. Portal Hypertensive Intestinal Vasculopathy; T. R. Viggiano. 26. Role of Lipopolysaccharide and Inducible Nitric Oxide Synthase in Gastrointestinal and Hepatic Disease: Actions of Selective Inhibition of iNOS on Microvascular Integrity in the Gut and Liver; F. Laszlo, et al. 27. Bacterial Overgrowth in the Small Intestine in Chronic Liver Disease; F. Casafont, et al. Section VI: Spontaneous Bacterial Peritonitis in Cirrhotics. 28. Spontaneous Bacterial Peritonitis Incidence, Diagnosis and Clinical Course; A. Ochs. 29. Treatment and Prophylaxis of Spontaneous Bacterial Peritonitis; A. Rimola, et al. Section VII: Liver Injury in Patients with Diseases of the Gastrointestinal Tract. 30. Haemochromatosis: A Defect in Gut Transport Leads to Liver Injury; W. Stremmel, et al. 31. Liver and Biliary Abnormalities in Ulcerative Colitis and Crohn's Disease; R. H. Wiesner. 32. Liver Abnormalities in Coeliac Disease; M. B. Jacobsen. 33. Primary Sclerosing Cholangitis: New Therapeutic Strategies; A. Stiehl, et al. 34. Jejunoileal Bypass: An Unintended Model of Steatophepatitis (Nash Syndrome) in Man; D. L. Kaminski. Index."